FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

PEGINTRON (peginterferon alfa-2b) Vials
Status: Discontinuation
»Therapeutic Categories: Antiviral

Expand all

Merck Sharp & Dohme Corp. (New 09/24/2015)

Company Contact Information:
800-672-6372

Presentation Posting Date Related Information
PEGINTRON (peginterferon alfa-2b) injection, 80 mcg per 0.5 mL (NDC 00085-4354-01) 09/24/2015 For business reasons, Merck has decided to voluntarily discontinue the manufacture of PEGINTRON vials, Injection, for subcutaneous use, for distribution in the United States, effective date of February 1, 2016.
PEGINTRON (peginterferon alfa-2b) injection, 120 mcg per 0.5 mL (NDC 00085-4355-01) 09/24/2015 For business reasons, Merck has decided to voluntarily discontinue the manufacture of PEGINTRON vials, Injection, for subcutaneous use, for distribution in the United States, effective date of February 1, 2016.
PEGINTRON (peginterferon alfa-2b) injection, 150 mcg per 0.5 mL (NDC 00085-4356-01) 09/24/2015 For business reasons, Merck has decided to voluntarily discontinue the manufacture of PEGINTRON vials, Injection, for subcutaneous use, for distribution in the United States, effective date of February 1, 2016.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.